Improving vascularization of tissue-engineered oral mucosa (TEM) is a major challenge in the field of plastic surgery. Hypoxia is a stimulator of angiogenesis through a number of mechanisms. Therefore, hypoxia is a critical parameter that can be controlled in an effort to improve angiogenesis. In the present study we studied the secretion of a number of angiogenic factors during hypoxia exposure and evaluated the effect of TEM conditioned medium on endothelial cells. TEM was constructed by seeding human oral mucosa keratinocytes and fibroblasts on acellular human donor skin. TEM was exposed to hypoxia during 6, 12, and 24 h. Cellular hypoxia was assessed by immunolocalization of the hypoxia-inducible factor-1α. Secretion of vascular endothelial growth factor, placental growth factor (PlGF), tissue inhibitors of matrix metalloproteinases-1 and -2, and the activity of matrix metalloproteinase-9 significantly increased during hypoxia exposure. Moreover, conditioned medium from hypoxic TEM strongly enhanced endothelial cell proliferation and migration. In vitro exposure of TEM to hypoxia improves its capacity to support endothelial cell proliferation and migration, which suggests that hypoxia preconditioning of TEM potentially improves angiogenic responses for in vivo implantation.
Get full access to this article
View all access options for this article.
References
1.
NeliganP.C., GullaneP.J., GilbertR.W.Functional reconstruction of the oral cavity. World J Surg, 27:856. 2003.
2.
AveryC.M., PereiraJ., BrownA.E.Suprafascial dissection of the radial forearm flap and donor site morbidity. Int J Oral Maxillofac Surg, 30:37. 2001.
3.
GrahamB., AdkinsP., SchekerL.R.Complications and morbidity of the donor and recipient sites in 123 lateral arm flaps. J Hand Surg Br, 17:189. 1992.
4.
KimataY., UchiyamaK., EbiharaS., SaikawaM., HayashiR., HanedaT., OhymaW., KishimotoS., AsaiM., NakatsukaT., HariiK.Postoperative complications and functional results after total glossectomy with microvascular reconstruction. Plast Reconstr Surg, 106:1028. 2000.
5.
ChoK.H., AhnH.T., ParkK.C., ChungJ.H., KimS.W., SungM.W., KimK.H., ChungP.H., EunH.C., YounJ.I.Reconstruction of human hard-palate mucosal epithelium on de-epidermized dermis. J Dermatol Sci, 22:117. 2000.
6.
YoshizawaM., FeinbergS.E., MarceloC.L., ElnerV.M.Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system. J Oral Maxillofac Surg, 62:980. 2004.
7.
OphofR., van RhedenR.E., Von denH.J., SchalkwijkJ., Kuijpers-JagtmanA.M.Oral keratinocytes cultured on dermal matrices form a mucosa-like tissue. Biomaterials, 23:3741. 2002.
8.
MoharamzadehK., BrookI.M., Van NoortR., ScuttA.M., ThornhillM.H.Tissue-engineered oral mucosa: a review of the scientific literature. J Dent Res, 86:115. 2007.
9.
RakhorstH.A., Posthumus-Van SluijsS.J., TraW.M., Van NeckJ.W., Van OschG.J., HoviusS.E., El GhalbzouriA., HoferS.O.Fibroblasts accelerate culturing of mucosal substitutes. Tissue Eng, 12:2321. 2006.
10.
IzumiK., SongJ., FeinbergS.E.Development of a tissue-engineered human oral mucosa: from the bench to the bed side. Cells Tissues Organs, 176:134. 2004.
11.
OphofR., MalthaJ.C., Kuijpers-JagtmanA.M., Von den HoffJ.W.Implantation of tissue-engineered mucosal substitutes in the dog palate. Eur J Orthod, 30:1. 2008.
12.
BoyceS.T., SuppA.P., HarrigerM.D., GreenhalghD.G., WardenG.D.Topical nutrients promote engraftment and inhibit wound contraction of cultured skin substitutes in athymic mice. J Invest Dermatol, 104:345. 1995.
13.
SumiY., HataK.I., SawakiY., MizunoH., UedaM.Clinical application of cultured oral epithelium for palatal wounds after palatoplasty: a preliminary report. Oral Dis, 5:307. 1999.
14.
KellyB.D., HackettS.F., HirotaK., OshimaY., CaiZ., Berg-DixonS., RowanA., YanZ., CampochiaroP.A., SemenzaG.L.Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res, 93:1074. 2003.
15.
KroonM.E., KoolwijkP., van der VechtB., van HinsberghV.W.Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. J Cell Sci, 114:825. 2001.
16.
ThangarajahH., YaoD., ChangE.I., ShiY., JazayeriL., VialI.N., GalianoR.D., DuX.L., GroganR., GalvezM.G., JanuszykM., BrownleeM., GurtnerG.C.The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues. Proc Natl Acad Sci USA, 106:13505. 2009.
17.
ThangarajahH., VialI.N., ChangE., El-FtesiS., JanuszykM., ChangE.I., PaternoJ., NeofytouE., LongakerM.T., GurtnerG.C.IFATS collection: adipose stromal cells adopt a proangiogenic phenotype under the influence of hypoxia. Stem cells (Dayton, Ohio), 27:266. 2009.
18.
RheinwaldJ.G., GreenH.Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell, 6:331. 1975.
19.
PonecM., WeerheimA., KempenaarJ., MommaasA.M., NugterenD.H.Lipid composition of cultured human keratinocytes in relation to their differentiation. J Lipid Res, 29:949. 1988.
20.
RakhorstH.A., TraW.M., Posthumus-Van SluijsS.T., HoviusS.E., LevendagP.C., KanaarR., HoferS.O.Quantitative analysis of radiation-induced DNA break repair in a cultured oral mucosal model. Tissue Eng, 12:3395. 2006.
21.
El GhalbzouriA., LammeE., PonecM.Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res, 310:189. 2002.
22.
MaldaJ., KleinT.J., UptonZ.The roles of hypoxia in the in vitro engineering of tissues. Tissue Eng, 13:2153. 2007.
23.
NakanishiY., IzumiK., YoshizawaM., SaitoC., KawanoY., MaedaT.The expression and production of vascular endothelial growth factor in oral mucosa equivalents. Int J Oral Maxillofac Surg, 36:928. 2007.
24.
XuQ., IzumiK., TobitaT., NakanishiY., FeinbergS.E.Constitutive release of cytokines by human oral keratinocytes in an organotypic culture. J Oral Maxillofac Surg, 67:1256. 2009.
25.
AbaciH.E., TruittR., LuongE., DrazerG., GerechtS.Adaptation to oxygen deprivation in cultures of human pluripotent stem cells, endothelial progenitor cells, and umbilical vein endothelial cells. Am J Physiol Cell Physiol, 298:C1527. 2010.
26.
CarmelietP., MoonsL., LuttunA., VincentiV., CompernolleV., De MolM., WuY., BonoF., DevyL., BeckH., ScholzD., AckerT., DiPalmaT., DewerchinM., NoelA., StalmansI., BarraA., BlacherS., VandendriesscheT., PontenA., ErikssonU., PlateK.H., FoidartJ.M., SchaperW., Charnock-JonesD.S., HicklinD.J., HerbertJ.M., CollenD., PersicoM.G.Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med, 7:575. 2001.
27.
AsaharaT., TakahashiT., MasudaH., KalkaC., ChenD., IwaguroH., InaiY., SilverM., IsnerJ.M.VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J, 18:3964. 1999.
28.
van HinsberghV.W., EngelseM.A., QuaxP.H.Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol, 26:716. 2006.
29.
BrewK., DinakarpandianD., NagaseH.Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta, 1477:267. 2000.
30.
BrewK., NagaseH.The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta, 1803:55. 2010.
31.
EgebladM., WerbZ.New functions for the matrix metalloproteinases in cancer progression. Nat Rev, 2:161. 2002.
32.
MottJ.D., WerbZ.Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol, 16:558. 2004.
33.
van HinsberghV.W., KoolwijkP.Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead. Cardiovasc Res, 78:203. 2008.
34.
GriffithC., GeorgeS.The effect of hypoxia on in vitro prevascularization of a thick soft tissue. Tissue Eng, 15:2423. 2009.
TrentinD., HallH., WechslerS., HubbellJ.A.Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci USA, 103:2506. 2006.
SemenzaG.L.Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol, 15:551. 1999.
39.
KellnerK., LiebschG., KlimantI., WolfbeisO.S., BlunkT., SchulzM.B., GopferichA.Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng, 80:73. 2002.
40.
RadisicM., MaldaJ., EppingE., GengW., LangerR., Vunjak-NovakovicG.Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng, 93:332. 2006.
41.
DasR., JahrH., van OschG., FarrellE.The role of hypoxia in MSCs: considerations for regenerative medicine approaches. Tissue Eng, 16:159. 2010.
42.
StraseskiJ.A., GibsonA.L., Thomas-VirnigC.L., Allen-HoffmannB.L.Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen. Wound Repair Regen, 17:606. 2009.
43.
GillE.M., StraseskiJ.A., RasmussenC.A., LiliensiekS.J., EliceiriK.W., RamanujamN., WhiteJ.G., Allen-HoffmannB.L.Visualization of morphological and molecular features associated with chronic ischemia in bioengineered human skin. Microsc Microanal, 16:117. 2010.
44.
OberleyC.C., GourroncF., HakimiS., RiordanM., BronnerS., JiaoC., DunnwaldM.Murine epidermal side population possesses unique angiogenic properties. Exp Cell Res, 314:720. 2008.
45.
DetmarM., BrownL.F., BerseB., JackmanR.W., ElickerB.M., DvorakH.F., ClaffeyK.P.Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol, 108:263. 1997.
46.
SteinbrechD.S., LongakerM.T., MehraraB.J., SaadehP.B., ChinG.S., GerretsR.P., ChauD.C., RoweN.M., GittesG.K.Fibroblast response to hypoxia: the relationship between angiogenesis and matrix regulation. J Surg Res, 84:127. 1999.
47.
LiT.S., HamanoK., SuzukiK., ItoH., ZempoN., MatsuzakiM.Improved angiogenic potency by implantation of ex vivo hypoxia prestimulated bone marrow cells in rats. Am J Physiol Heart Circ Physiol, 283:H468. 2002.
48.
RosovaI., DaoM., CapocciaB., LinkD., NoltaJ.A.Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem cells (Dayton, Ohio), 26:2173. 2008.
49.
BlackA.F., BerthodF., L'HeureuxN., GermainL., AugerF.A.In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J, 12:1331. 1998.
50.
SuppD.M., Wilson-LandyK., BoyceS.T.Human dermal microvascular endothelial cells form vascular analogs in cultured skin substitutes after grafting to athymic mice. FASEB J, 16:797. 2002.
51.
SahotaP.S., BurnJ.L., BrownN.J., MacNeilS.Approaches to improve angiogenesis in tissue-engineered skin. Wound Repair Regen, 12:635. 2004.
52.
PonecM., El GhalbzouriA., DijkmanR., KempenaarJ., van der PluijmG., KoolwijkP.Endothelial network formed with human dermal microvascular endothelial cells in autologous multicellular skin substitutes. Angiogenesis, 7:295. 2004.
53.
TrottierV., Marceau-FortierG., GermainL., VincentC., FradetteJ.IFATS collection: using human adipose-derived stem/stromal cells for the production of new skin substitutes. Stem Cells, 26:2713. 2008.
54.
SuppD.M., BoyceS.T.Overexpression of vascular endothelial growth factor accelerates early vascularization and improves healing of genetically modified cultured skin substitutes. J Burn Care Rehabil, 23:10. 2002.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
